![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
CR Albrightson, P Nambi, B Zabko-Potapovich, G Dytko and T Groom
Department of Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania.
The effect of thrombin on mesangial cell function was investigated. Thrombin caused a dose-dependent increase in [3H] thymidine incorporation (EC50 = 0.36 +/- 0.09 U/ml), intracellular calcium [(Ca++)i] mobilization (EC50 = 1.9 +/- 0.5 U/ml) and prostaglandin E2 (PGE2) production (EC50 = 0.25 +/- 0.02 U/ml) in rat glomerular mesangial cells. These effects were blocked by the thrombin inhibitor, hirudin (KB = 10.4 +/- 0.2 nM). The role of (Ca++)i mobilization and arachidonate metabolism in thrombin-stimulated proliferation was tested by the addition of the calcium channel blocker, nifedipine, and the cyclooxygenase inhibitor, indomethacin, to mesangial cell cultures. Indomethacin, at doses that completely inhibited the thrombin-mediated production of PGE2, had no significant effect on proliferation. The Ca++ channel blocker, nifedipine, inhibited both PGE2 production and [3H] thymidine incorporation in a dose-dependent fashion, but only at concentrations considered nonspecific. In addition to its effects on PGE2, thymidine incorporation and Ca++ mobilization, thrombin caused mesangial cell contraction as determined by a substrate distortion technique. This effect was not inhibited by indomethacin. These results indicate that thrombin can alter mesangial cell function in vitro.
This article has been cited by other articles:
|
|
 |
|
  S. Tsunoda, H. Yamabe, H. Osawa, M. Kaizuka, K. Shirato, and K. Okumura Cultured rat glomerular epithelial cells show gene expression and production of transforming growth factor-{beta}: expression is enhanced by thrombin Nephrol. Dial. Transplant., September 1, 2001; 16(9): 1776 - 1782. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. KUMAR, D. P. BROOKS, B. A. OLSON, and N. J. LAPING Sgk, a Putative Serine/Threonine Kinase, Is Differentially Expressed in the Kidney of Diabetic Mice and Humans J. Am. Soc. Nephrol., December 1, 1999; 10(12): 2488 - 2494. [Abstract] [Full Text]
|
|
|
|
|
|
M. KAIZUKA, H. YAMABE, H. OSAWA, K. OKUMURA, and N. FUJIMOTO Thrombin Stimulates Synthesis of Type IV Collagen and Tissue Inhibitor of Metalloproteinases-1 by Cultured Human Mesangial Cells J. Am. Soc. Nephrol., July 1, 1999; 10(7): 1516 - 1523. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. Murray, M. Wylam, and J. Umans Endotoxin impairs agonist-induced calcium mobilization in rat mesangial cells Am. J. Respir. Crit. Care Med., December 1, 1997; 156(6): 1846 - 1854. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. N. Inoue, H. G. Forster, and M. Epstein Effects of Lysophosphatidic Acid, a Novel Lipid Mediator, on Cytosolic Ca2+ and Contractility in Cultured Rat Mesangial Cells Circ. Res., November 1, 1995; 77(5): 888 - 896. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
